Resova Rusovastatin is a medication classified as a statin, specifically rosuvastatin, which acts by inhibiting HMG-CoA reductase, the enzyme involved in cholesterol synthesis. By lowering LDL cholesterol levels and triglycerides while increasing HDL cholesterol, Resova Rusovastatin helps reduce the risk of cardiovascular events. It is indicated for the treatment of hyperlipidemia, familial hypercholesterolemia, and mixed dyslipidemia. Clinical studies have shown that Resova Rusovastatin can significantly decrease the incidence of heart attacks, strokes, and the need for revascularization procedures. This medication is an essential component of managing dyslipidemia and preventing atherosclerotic cardiovascular disease.